Janiri, Luigi
 Distribuzione geografica
Continente #
EU - Europa 13.707
NA - Nord America 9.809
AS - Asia 6.541
SA - Sud America 1.343
AF - Africa 165
OC - Oceania 80
Continente sconosciuto - Info sul continente non disponibili 16
Totale 31.661
Nazione #
US - Stati Uniti d'America 9.488
IT - Italia 5.697
SG - Singapore 3.254
DE - Germania 2.925
CN - Cina 1.711
SE - Svezia 1.217
BR - Brasile 1.094
FR - Francia 765
UA - Ucraina 764
GB - Regno Unito 567
IE - Irlanda 365
VN - Vietnam 286
IN - India 277
PL - Polonia 257
ID - Indonesia 256
FI - Finlandia 233
RU - Federazione Russa 224
CA - Canada 193
NL - Olanda 193
HK - Hong Kong 119
TR - Turchia 115
AR - Argentina 93
CH - Svizzera 92
BD - Bangladesh 85
JP - Giappone 84
MX - Messico 80
ES - Italia 73
AU - Australia 68
BE - Belgio 62
AT - Austria 47
IQ - Iraq 44
CI - Costa d'Avorio 40
ZA - Sudafrica 40
IR - Iran 39
CO - Colombia 35
KR - Corea 33
RO - Romania 32
EC - Ecuador 30
PK - Pakistan 24
CZ - Repubblica Ceca 23
GR - Grecia 22
LT - Lituania 22
MA - Marocco 22
CL - Cile 21
IL - Israele 21
SA - Arabia Saudita 20
VE - Venezuela 19
AL - Albania 18
UZ - Uzbekistan 18
HU - Ungheria 17
AE - Emirati Arabi Uniti 16
PY - Paraguay 15
NP - Nepal 14
PE - Perù 14
KE - Kenya 13
AZ - Azerbaigian 12
DZ - Algeria 12
NZ - Nuova Zelanda 12
UY - Uruguay 12
DO - Repubblica Dominicana 11
KZ - Kazakistan 11
NO - Norvegia 11
EG - Egitto 10
JO - Giordania 10
MY - Malesia 10
PA - Panama 10
PT - Portogallo 10
TH - Thailandia 10
KG - Kirghizistan 9
RS - Serbia 9
BO - Bolivia 8
MT - Malta 8
OM - Oman 8
PH - Filippine 8
A1 - Anonimo 7
DK - Danimarca 7
HR - Croazia 7
LB - Libano 7
LV - Lettonia 7
TN - Tunisia 7
TW - Taiwan 7
AM - Armenia 6
BY - Bielorussia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
LU - Lussemburgo 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
CR - Costa Rica 4
JM - Giamaica 4
LK - Sri Lanka 4
MN - Mongolia 4
NG - Nigeria 4
PS - Palestinian Territory 4
QA - Qatar 4
EE - Estonia 3
ET - Etiopia 3
EU - Europa 3
MC - Monaco 3
MD - Moldavia 3
SN - Senegal 3
Totale 31.613
Città #
Chandler 1.575
Singapore 1.554
Ashburn 927
Milan 679
Rome 574
Jacksonville 413
San Mateo 378
Dublin 356
Beijing 288
New York 283
Wilmington 267
Jakarta 230
Nanjing 228
Woodbridge 217
Los Angeles 215
Warsaw 193
Ann Arbor 163
Houston 159
Boston 152
Dearborn 151
Hefei 143
Redwood City 143
Dallas 133
Nürnberg 133
Moscow 130
Munich 121
Seattle 121
Fairfield 114
Frankfurt am Main 110
Ho Chi Minh City 110
Lawrence 106
The Dalles 103
São Paulo 101
Nanchang 100
Bremen 96
Hong Kong 94
Cattolica 91
Marseille 91
Princeton 89
Naples 88
Florence 79
Buffalo 76
Norwalk 72
Turin 71
Bologna 68
Hanoi 68
Chicago 62
Lancaster 61
Guangzhou 58
Boardman 56
Mountain View 54
London 53
Bari 51
Genoa 51
University Park 51
Falls Church 49
Hebei 47
Tokyo 46
Helsinki 45
Brussels 44
Catania 44
Pune 44
Toronto 44
Shenyang 43
Hangzhou 42
Cambridge 41
Changsha 41
Paris 41
Verona 41
Abidjan 40
Palermo 39
Brescia 38
Düsseldorf 38
Fremont 38
Rio de Janeiro 38
Kunming 37
Kent 36
Shanghai 36
Montreal 35
Tianjin 35
Izmir 33
Santa Clara 33
Brooklyn 32
Columbus 32
Chennai 29
Stockholm 29
Belo Horizonte 27
Jiaxing 27
Denver 26
Padova 26
Atlanta 25
Nuremberg 25
Vienna 25
Andover 24
Orem 24
Mexico City 23
Seoul 23
Lauterbourg 22
Ottawa 22
Philadelphia 22
Totale 13.701
Nome #
L efficacia del topiramato a basso dosaggio in pazienti alcolisti in fase di post-disintossicazione 2.859
Manuale di Riabilitazione per i Disturbi dell’Umore 925
Psychometric characteristic of the Italian version of the Temperament and Character Inventory--revised, personality, psychopathology, and attachment styles 624
Quetiapine as add-on treatment for Bipolar I Disorder with comorbid compulsive buying and physical exercise addiction 520
Comorbilità tra Disturbi da Uso di Sostanze e disturbi affettivi 411
Monocytes from depressed patients display an altered pattern of response to endotoxin challenge 390
New perspectives on generalized anxiety disorder 386
Craving Typology Questionnaire (CTQ): a scale for alcohol craving in normal controls and alcoholics 380
Bipolar disorder and gambling disorder comorbidity: current evidence and implications for pharmacological treatment 305
Description and validation of a questionnaire for the detection of meteoropathy and meteorosensitivity: the METEO-Q 298
Childhood trauma, resilience and depression 277
PSYCHOMETRIC TESTS AND RISK FACTORS FOR SCREENING OF MOOD DISORDERS IN PREGNANCY AND POST-PARTUM: A PRELIMINARY STUDY. 273
Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial 242
Alterazioni delle risposte immuno-infiammatorie nei pazienti affetti da disturbo depressivo maggiore (Immune-inflammatory response changes in patients with major depressive disorder) 240
Behavioural addictions in bipolar disorder patients: Role of impulsivity and personality dimensions 240
Alcol e lavoro. Documento di consenso del gruppo LaRA 240
Programma di trattamento integrato in regime di day hospital per pazienti depressi “difficili” da trattare. 239
Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. 232
Cognitive markers of psychotic unipolar depression: A meta-analytic study 225
Bipolar Disorder Questionnaire for the Assessment of Learning: a New Instrument for Studying Information Acquisition in Psychoeducational programs. 220
Neuroendocrinologia dei disturbi dell umore 206
Augmentation of drug treatment with bright light therapy in patients with difficult-to-treat depression: acute and long term observation 197
Dopamine transporter availability in gambling disorder: preliminary 123I-FP-CIT SPECT results 187
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up. 185
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study] 184
Pharmacological Treatment of Internet Addiction 182
Association of polymorphism (Val66Met) of brain-derived neurotrophic factor with suicide attempts in depressed patients 176
Depression, inflammation and coronary heart disease: prognostical value of C-reactive protein and depressive symptoms. 176
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 174
Il trattamento integrato dei Disturbi dell’Umore: "Il ruolo dei farmaci" 172
Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a (123)I-FP-CIT SPECT study 171
Striatal dopamine transporter (DAT) availability and affective symptoms in movement disorders: a 123I-FP-CIT SPECT study. 170
Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial 169
Role of Substance Abuse Comorbidity and Personality on the Outcome of Depression in Bipolar Disorder: Harm Avoidance Influences Medium-Term Treatment Outcome. 169
Problematic mobile phone use in adolescence: A cross-sectional study 169
A Role for Pharmacotherapy in the Treatment of “Internet Addiction” 169
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study]. 163
Plasma magnesium levels and treatment outcome in depressed patients 163
Low-dose topiramate in alcohol dependence: a single-blind, placebo-controlled study 162
[Separation anxiety disorder: evidence of literature and clinical implications] 161
Clinical insights by the presence of bipolar disorder in pseudohypoparathyroidism type 1A 160
Treatment of prurigo nodularis with pregabalin. 159
Adult attention-deficit/hyperactivity disorder in major depressed and bipolar subjects: role of personality traits and clinical implications 156
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 156
The importance of cognitive assessment in the management of psychiatric disorders 156
Reduced hedonic capacity in euthymic bipolar subjects: A trait-like feature? 155
An observational study evaluating comorbidity between bipolar disorder and personality disorders 152
Temperament and attachment in alcohol addicted patients of type 1 and 2 152
Factors associated with the course of symptoms in bipolar disorder during a 1-year follow-up: depression vs. sub-threshold mixed state 149
Plasma magnesium levels and treatment outcome in depressed patients 147
Polysomnographic Findings in a Cohort of Chronic Insomnia Patients with Benzodiazepines Abuse 147
Topiramate in Alcohol Use Disorders: Review and Update. 147
Clinical Presentation 145
Cognitive markers of psychotic unipolar depression: A meta-analytic study 145
Role of substance abuse comorbidity and personality on the outcome of depression in bipolar disorder: harm avoidance influences medium-term treatment outcome 144
Alcohol protracted withdrawal syndrome: the role of anhedonia 144
Changes of Dopamine Transporter Availability in Depressed Patients with and without Anhedonia: A 123I-N-ω-Fluoropropyl-Carbomethoxy-3β-(4-Iodophenyl)tropane SPECT Study 144
Organizzazione di un gruppo di Auto-Mutuo-Aiuto “Facilitato” per pazienti depressi. 142
Depression Symptoms and Clinical Subtypes in Parkinson's Disease Patients: a I-123-FP-CIT SPECT Study 142
Affective dependence and aggression: an exploratory study 142
Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. 141
Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up 141
Gender Differences and Psychopathological Features Associated With Addictive Behaviors in Adolescents. 140
Behavioural addictions in adolescents and young adults: results from a prevalence study. 139
PRELIMINARY ANALYSIS OF GENES INVOLVED IN INFLAMMATORY, OXIDATIVE PROCESSES AND CA2+SIGNALING IN BIPOLAR DISORDER AND COMORBIDITY FOR SUBSTANCE USE DISORDER 139
Affective temperaments and psychopathological dimensions of personality in bipolar and cyclothymic patients 139
Pregabalin augmentation in treatment-resistant obsessive-compulsive disorder: a 16-week case series 138
Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study 138
Il trattamento della schizofrenia 137
Traumatic life experiences and major depression: an overview 136
Organizzazione di un gruppo di psicoeducazione per pazienti bipolari. 135
Affective temperament and attachment in adulthood in patients with Bipolar Disorder and Cyclothymia 134
Co-occurrence of alcohol use disorder and behavioral addictions: relevance of impulsivity and craving 132
Clinical correlates of difficult-to-treat depression: Exploring an integrated day-care model of treatment 132
Acetyl-L-carnitine for alcohol craving and relapse prevention in anhedonic alcoholics: a randomized, double-blind, placebo-controlled pilot trial. 131
Augmentation of light therapy in difficult-to-treat depressed patients: an open-label trial in both unipolar and bipolar patients 131
Predictive value of magnesium levels in depressed patients. 130
Mental health during and after the COVID-19 emergency in Italy 130
Treatment of prurigo nodularis with pregabalin 129
Allostasis as a conceptual framework linking bipolar disorder and addiction 129
Serotoninergic and dopaminergic genes in bipolar disorder and response to treatments in bipolar depression. Investigation on a well-characterized naturalistic sample 128
Further evidence supporting the association between 5HTR2C gene and bipolar disorder 128
Managing disruptive and compulsive behaviors in adult with autistic disorder with gabapentin 128
Temperament and character profiles in bipolar I, bipolar II and major depressive disorder: Impact over illness course, comorbidity pattern and psychopathological features of depression 128
Serum 25-hydroxyvitamin D levels and psychological distress symptoms in patients with affective disorders during the COVID-19 pandemic 128
Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance 127
Somatic symptoms and high-sensitive C-reactive protein in major depression 127
The assessment of post-detoxification anhedonia: influence of clinical and psychosocial variables 127
Empathy and attitudes towards mental illness among Italian medical students 126
Duloxetine for premenstrual dysphoric disorder: a pilot study 125
Targeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives 125
Pharmacological treatments in alcohol use disorders: state of art and new perspectives 125
A Mixed Program of Psychoeducational and Psychological Rehabilitation for Patients With Bipolar Disorder in a Day Hospital Setting. 125
Pharmacological and Psychosocial Treatment of Adults With Gambling Disorder: A Meta-Review 125
Acetyl-l-Carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjects 124
Anomalous self-experience, body image disturbance, and eating disorder symptomatology in first-onset anorexia nervosa 123
Mood, hormones and quality of life. 122
Family history of suicide and personality 121
Impulsivity, alexithymia and dissociation among pathological gamblers in different therapeutic settings: A multisample comparison study 120
Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview 119
Totale 21.217
Categoria #
all - tutte 113.449
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.449


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.189 0 0 0 0 0 99 275 64 241 171 271 68
2021/20222.245 193 184 60 109 114 103 108 365 140 154 334 381
2022/20235.314 595 614 372 752 365 558 334 496 607 152 267 202
2023/20243.288 225 667 165 243 196 442 171 157 138 189 355 340
2024/20255.246 260 255 409 277 496 223 191 328 760 487 816 744
2025/20266.103 1.442 359 660 1.135 2.147 360 0 0 0 0 0 0
Totale 31.888